> No clinical efficacy, safety, pharmacology, non-clinical or manufacturing issues were raised and noadditional clinical studies are required by FDA to support NDA approval
Pretty happy with that all things considered.
> No clinical efficacy, safety, pharmacology, non-clinical or...
-
- There are more pages in this discussion • 281 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $671.1M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.8¢ | $954.2K | 2.577M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 89025 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 1729 | 1 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |